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Antagonistic effects of atipamezole, flumazenil and 4-aminopyridine on anesthesia and 
stress-related neurohormonal and metabolic changes induced by medetomidine, midazolam and ketamine 
in cats 
 The 2-adrenoceptor agonist medetomidine (MED) is mainly used for sedation and analgesia 
in veterinary medicine. However, it induces undesirable effects such as hyperglycemia, hypoinsulinemia, 
emesis, diuresis and bradyarrhythmias in dogs and cats. The combination of MED, the benzodiazepine 
agonist midazolam (MID) and the dissociative anesthetic agent ketamine (KET) produce good anesthesia in 
cats with excellent muscle relaxation and analgesia. Antagonism may be required when the anesthetized 
animals show a profound depression of vital signs, adverse effects and/or delayed recovery from anesthesia. 
Atipamezole (ATI), flumazenil (FLU) and 4-aminopyridine (4AP) completely or partially antagonize the 
effects of MED, MID and KET, respectively, in cats. Stressors such as anxiety, excitement, pain and 
anesthesia are known to induce neurohormonal and metabolic changes. These changes are characterized by 
increases in blood levels of cortisol, catecholamines, glucose and non-esterified fatty acids (NEFA) and a 
decrease in blood insulin levels. Actions mediated by 2-adrenoceptors are closely coordinated with these 
events. However, there is no report on stress-related neurohormonal and metabolic influences of 
antagonism against the anesthesia with MED MID KET in cats. The present study aimed to investigate the 
effects of ATI, FLU and 4AP, both alone and in various combinations, on anesthesia and key stress-related 
neurohormonal and metabolic changes induced by MED MID KET in healthy cats. 
In chapter 1, the antagonistic effects of ATI, FLU and 4AP alone and their combinations after anesthesia 
produced by a fixed dose of MED, MID and KET injected intramuscularly were evaluated in cats. Eight 
cats received eight different treatments. Each cat was given the mixture of 0.05 mg/kg MED and 0.5 mg/kg 
MID followed 10 min later by 10 mg/kg KET intramuscularly. Twenty min after KET injection, the cats 
were given either physiological saline solution (PSS) at a dose of 0.1 ml/kg (control), 0.2 mg/kg ATI, 0.1 
mg/kg FLU, 0.5 mg/kg 4AP, ATI FLU, FLU 4AP, ATI 4AP or ATI FLU 4AP intravenously. Elapsed 
times to recovery of the palpebral reflex, pedal reflex and tail clamp reflex were recorded 13 times over 300 
min period after the injection of antagonists. Recovery times to head movement, sternal recumbency, 
standing and walking were also recorded. The degree of antagonism for anesthesia was assessed using 
previously published scoring methods. Mean elapsed times to recovering the eyelid, pedal and tail clamp 
reflex after injection of potential antagonists were significantly shortened in the antagonists-injected groups 
compared with the PSS-injected control. The cats in the ATI group had a significantly lower total score 
compared with PSS or non-ATI injected groups. The cats in the ATI FLU 4AP group had the lowest total 
score after antagonist injection compared with the other groups. Rectal temperature decreased significantly 
or tended to decrease from pre-values until 240 min in the control and non-ATI injected groups. Rectal 
temperature in ATI, ATI FLU and ATI 4AP groups recovered to pre-values at 180 min after administration 
of antagonists. Heart rates and respiratory rates in the ATI combined groups were significantly higher than 
those in control and non-ATI injected groups after injection of antagonists. However, the cats in the 
ATI FLU 4AP group showed tachycardia and tachypnea. Excitement, vocalizing, aversion to body touch 
and congestion of the conjunctiva were observed in some of cats received combinations with ATI and in 
most of the cats received ATI FLU 4AP. In addition, muscle tremors were observed in many cats that 
received ATI 4AP and ATI FLU 4AP. Emesis was observed in the control and non-ATI injected groups 
during recovery. These results demonstrated that either FLU or 4AP alone did not markedly antagonize 
MED MID KET anesthesia. ATI alone and combinations with ATI are much more effective for 
antagonizing the anesthesia and side effects induced by MED MID KET. ATI alone can be used as a safe 
and effective agent for antagonizing the MED MID KET anesthesia in cats. However, the use of 
ATI FLU 4AP may be not always produce smooth recovery from anesthesia.  
In chapter 2, the effects of ATI, FLU and 4AP, both alone and in various combinations on key 
stress-related neurohormonal and metabolic variables after anesthesia with MED MID KET were 
investigated in healthy cats. Seven cats received eight different treatments. Experimental groups and 
dosages of tested agents were same as those in chapter 1. Blood samples were collected 10 times during the 
24-h test period from a central venous catheter introduced into the jugular vein. Plasma glucose, insulin, 
cortisol, epinephrine, norepinephrine and NEFA concentrations were measured. MED MID KET 
administration resulted in hyperglycemia and decreases in epinephrine, norepinephrine and NEFA 
concentrations. FLU or 4AP alone or FLU 4AP combination did not effectively antagonize the effects 
induced by MED MID KET but enhanced hyperglycemia. ATI alone was effective in antagonizing these 
effects. Compared with non-ATI regimens, combinations with ATI were more effective in antagonizing the 
effects induced by MED MID KET; however, ATI FLU 4AP caused large increases in cortisol, 
epinephrine and norepinephrine concentrations. ATI, both alone and in combination, is effective in 
antagonizing the neurohormonal and metabolic effects of MED MID KET in cats. However, the 
ATI FLU 4AP combination is not suitable because of large stress-related hormonal responses. 
In conclusion, this study revealed that ATI, both alone and in combination, is effective in antagonizing 
the neurohormonal and metabolic effects of MED MID KET in cats. The use of 4AP and FLU is not 
clinically recommended in the antagonism of the hormonal and metabolic effects induced by 
MED MID KET. ATI alone may give appropriate antagonism without large stress responses for the 
recovery from anesthesia. However, the triple combination is not suitable for smooth antagonism because of 
large stress-related hormonal responses, as well as poor recovery from anesthesia, including 
hypersensitivity and aggression. This study provided new information on the antagonism for anesthesia 
with MED MID KET and its stress-related hormonal and metabolic changes in cats.  


